The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Feasibility study of gallium-68 citrate PET as a bone-tropic imaging biomarker in mCRPC.
 
Ivan de Kouchkovsky
No Relationships to Disclose
 
Spencer Behr
Consulting or Advisory Role - Advanced Accelerator Applications; Advanced Accelerator Applications; GenVivo; More Health; Progenics
Research Funding - Cancer Targeted Technology
 
Li Zhang
Consulting or Advisory Role - Dendreon; Fortis; Unity Biotechnology
Travel, Accommodations, Expenses - Dendreon; Dendreon; Dendreon
 
Adam Foye
No Relationships to Disclose
 
Henry Vanbrocklin
Consulting or Advisory Role - ProLynx
 
Eric Jay Small
Stock and Other Ownership Interests - Fortis; Harpoon Therapeutics
Honoraria - Janssen
Consulting or Advisory Role - Beigene; Fortis; Janssen Oncology; Teon Therapeutics; Tolero Pharmaceuticals
Research Funding - Janssen (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Janssen
 
Felix Y Feng
Leadership - PFS Genomics
Stock and Other Ownership Interests - PFS Genomics
Honoraria - Genentech
Consulting or Advisory Role - Astellas Pharma; Blue Earth Diagnostics; Celgene; Genentech; Janssen Biotech; Myovant Sciences; Roivant; SerImmune
Research Funding - Zenith Epigenetics
Patents, Royalties, Other Intellectual Property - I helped develop a molecular signature to predict radiation resistance in breast cancer, and this signature was patented by the University of Michigan, my employer. It is in the process of being licensed to PFS Genomics, a company that I helped found. (Inst)
 
Terence W. Friedlander
Leadership - Med BioGene
Honoraria - AstraZeneca/MedImmune; EMD Serono; Seattle Genetics/Astellas; Seattle Genetics/Astellas
Consulting or Advisory Role - Abbvie; Abbvie; AstraZeneca; Dava Oncology; Dendreon; Foundation Medicine; Janssen; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Incyte (Inst); Janssen; Neon Therapeutics (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Genentech/Roche; Jounce Therapeutics
 
Patricia Li
No Relationships to Disclose
 
Natalie Frey
No Relationships to Disclose
 
Andy Chung
Stock and Other Ownership Interests - Novavax
 
Austin Lui
No Relationships to Disclose
 
Aishwarya Subramanian
No Relationships to Disclose
 
Tammy J. Rodvelt
No Relationships to Disclose
 
Brigid Barlesi
Consulting or Advisory Role - Pfizer
Speakers' Bureau - Janssen
 
Michael Evans
Stock and Other Ownership Interests - Abbvie; ABION; Apple; AstraZeneca; Corcept Therapeutics; Deciphera; Inovio Pharmaceuticals; Johnson & Johnson; Lantheus Medical Imaging; Merck; Moderna Therapeutics; Navidea; Nektar; Novartis; ORIC Pharmaceuticals; Pfizer
 
Rahul Raj Aggarwal
Honoraria - Clovis Oncology
Consulting or Advisory Role - AstraZeneca; Dendreon; Janssen
Research Funding - Abbvie (Inst); Amgen (Inst); Cancer Targeted Technology (Inst); Janssen (Inst); Merck (Inst); Novartis (Inst); Xynomic Pharma (Inst); Zenith Epigenetics (Inst)
Travel, Accommodations, Expenses - Xynomic Pharma